# Boston Scientific Corporation (BSX) — Q1-2012 Earnings Results

**Report date:** 2012-04-19 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q1-2012

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Up 5.6%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.15 | N/A | +87.50% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed confidence in their product pipeline and market position. They acknowledged challenges but remain focused on strategic growth.

**Key quotes:**

> Management highlighted strong performance in key product areas.

> They emphasized ongoing investments in innovation.

> The team remains focused on long-term growth despite market challenges.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's strong EPS performance indicates better-than-expected profitability, contributing to a 5.6% rise in stock price. The positive surprise in EPS suggests effective cost management and operational efficiency. However, the lack of revenue data and guidance leaves some uncertainty for investors looking for future growth indicators.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q1-2012_